ArticleJournal of neuroscience research2014

Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease).

Martin L Katz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.